22NW Fund GP, LLC

CIK 1770575 · last filed 2025-12-12

22NW Fund GP, LLC is a corporate insider who has filed 7 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing shows the insider sold $6.4M of FSTR on Dec 12, 2025. Across all open-market trades the lifetime net is −$8.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $52.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$52.64M

Companies

3

Total Filings

7

Lifetime Open-Market Net

-$8.54M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
FSTR	10%+ Owner	1,191,951	$39.58	$47.18M	-$11.94M	4	2025-12-12
CULP	10%+ Owner	1,621,601	$3.37	$5.46M	$1.84M	2	2024-12-20
MERRIMACK PHARMACEUTICALS INC (MACK) Delisted	10%+ Owner	1,225,696	$15.13	$18.54M	$1.57M	1	2019-04-17

Recent Filings

7 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2025-12-12	FSTR	Sell (S)	−237,685	-$6.37M	EDGAR
2025-12-10	FSTR	Sell (S)	−129,065	-$3.49M	EDGAR
2025-11-18	FSTR	Sell (S)	−13,235	-$357.3K	EDGAR
2025-11-13	FSTR	Sell (S)	−62,650	-$1.73M	EDGAR
2024-12-20	CULP	Buy (P)	+67,220	$352.4K	EDGAR
2024-07-10	CULP	Buy (P)	+306,865	$1.48M	EDGAR
2019-04-17	MERRIMACK PHARMACEUTICALS INC (MACK) Delisted	Buy (P)	+267,040	$1.57M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.